Thrombotics and Antithrombotics

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

Understanding the precise target of an antithrombotic dictates its clinical reversal strategy:

• Vitamin K Antagonists (Warfarin): Inhibits the synthesis of functional vitamin K-dependent coagulation factors (II, VII, IX, X) and proteins C and S.
• Factor Xa Inhibitors (Rivaroxaban, Apixaban, Edoxaban, Fondaparinux): Directly bind to and inhibit free and clot-bound Factor Xa in the common pathway, halting the conversion of prothrombin to thrombin.
• Direct Thrombin Inhibitors (Dabigatran, Bivalirudin, Argatroban): Directly bind to Factor IIa (Thrombin), preventing the conversion of fibrinogen to fibrin.
• Unfractionated Heparin (UFH) & Low-Molecular-Weight Heparin (LMWH): Bind to antithrombin, accelerating its inactivation of Thrombin and Factor Xa. LMWH has predominantly anti-Xa activity compared to UFH.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

Determine if the patient has Major Bleeding (life-threatening, >5 g/dL drop in Hb, intracranial hemorrhage, or planned neurosurgery). If major bleeding is present, immediately discontinue the anticoagulant and initiate targeted reversal:

• Warfarin Reversal: Administer Vitamin K 5–10 mg IV PLUS 4-Factor Prothrombin Complex Concentrate (4F-PCC / Kcentra).
• PCC Dosing: Either a fixed dose (1,000–5,000 units) or INR-based (INR 2-<4 = 25 U/kg; INR 4-6 = 35 U/kg; INR >6 = 50 U/kg).
• Dabigatran Reversal: Administer Idarucizumab (Praxbind) 5g IV (given as two 2.5g doses no more than 15 minutes apart). If unavailable, use 4F-PCC 50 U/kg (max 5000 units).
• Rivaroxaban / Apixaban Reversal: Administer Andexanet Alfa (Andexxa). Dosing depends on the specific drug, dose, and timing:
• Low-Dose Protocol (400 mg IV bolus, then 480 mg infusion over 2 hours): Use if last dose of Rivaroxaban was $\le$10 mg, Apixaban $\le$5 mg, or if an unknown dose was taken $\ge$8 hours prior.
• High-Dose Protocol (800 mg bolus, then 960 mg infusion over 2 hours): Use if Rivaroxaban >10 mg, Apixaban >5 mg, or unknown dose taken <8 hours prior.
• Alternative: 4F-PCC 25–50 U/kg (max 5000 units).
• UFH Reversal: Administer Protamine Sulfate 1 mg per 100 units of UFH given in the past 2 hours (Maximum dose: 50 mg).
• LMWH (Enoxaparin) Reversal: Administer Protamine Sulfate 1 mg per 1 mg of LMWH if given within 8 hours (Max 50 mg). Decrease to 0.5 mg per 1 mg if 8–12 hours have elapsed. No dosing is required if >12 hours.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• PT/INR: The primary monitoring tool for Warfarin. The goal of emergency reversal is to normalize the INR rapidly.
• aPTT: Used to monitor UFH infusions. Prolongation can also be seen with Direct Thrombin Inhibitors.
• Anti-Xa Levels: Routine monitoring is not required for DOACs, but specific anti-Xa levels can be highly useful to guide reversal strategies or confirm the presence of LMWH/Factor Xa inhibitors prior to emergent surgery.
• Heparin-Induced Thrombocytopenia (HIT): Suspect HIT if a patient on heparin develops a >50% drop in platelets or a new thrombotic event (e.g., skin necrosis, DVT). Immediately discontinue all heparin products and initiate a non-heparin anticoagulant like Argatroban or Bivalirudin.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• Ischemic Stroke (Hyperdense MCA Sign): A bright, hyperdense middle cerebral artery on a non-contrast head CT indicates a large vessel occlusion (LVO) and acute thrombus, warranting immediate neurology/interventional consultation for thrombectomy.
• Massive Pulmonary Embolism (POCUS D-Sign): Bedside echocardiography revealing right ventricular dilatation (RV/LV ratio > 1.0) and septal bowing into the left ventricle (creating a "D-shaped" left ventricle) indicates catastrophic right heart strain.
• Aortic Dissection (Contraindication to Lytics): POCUS or CTA identifying an intimal flap in the aorta is an absolute contraindication to antithrombotics and fibrinolytics.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• HAS-BLED Score: A validated tool used to predict the 1-year risk of major bleeding in patients with atrial fibrillation on anticoagulation. It evaluates Hypertension, Abnormal renal/liver function, Stroke, Bleeding history, Labile INR, Elderly, and Drugs/alcohol. A score $\ge$3 indicates high bleeding risk.
• 4Ts Score for HIT (Outside Information): Evaluates Thrombocytopenia (degree of drop), Timing (onset 5-10 days post-exposure), Thrombosis (new clot), and oTher causes. A score $\ge$4 indicates a moderate to high probability of HIT, mandating the immediate cessation of heparin and transition to a direct thrombin inhibitor.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• Deadly Pitfall (Systemic Fibrinolysis in Stroke): Administering systemic fibrinolytics (e.g., tPA/Alteplase) to an acute ischemic stroke patient who is taking any oral anticoagulant (DOAC or Warfarin) in the 3- to 4.5-hour extended window is an absolute contraindication, regardless of their current INR.
• Deadly Pitfall (Vitamin K Anaphylaxis): Administering IV Vitamin K via rapid push. It must be administered via a slow infusion (over 20 to 60 minutes) to prevent life-threatening anaphylaxis.
• Deadly Pitfall (LMWH Reversal): Relying on Protamine Sulfate to completely reverse LMWH. Protamine only partially neutralizes LMWH (approximately 50% effective).
• Critical Action (4F-PCC vs. FFP): In life-threatening bleeds (e.g., intracranial hemorrhage) on Warfarin, 4F-PCC is strongly preferred over Fresh Frozen Plasma (FFP). FFP requires 1 to 2 Liters of volume (high risk of fluid overload/TACO in the elderly), takes longer to thaw/administer, and corrects the INR slower than the low-volume, rapid-acting 4F-PCC.

7. MCQ MASTERCLASS (Written Exam Tips)

• Distractor Trap: A question describes a patient with a catastrophic intracranial hemorrhage taking Apixaban. A distractor option will be "Administer Idarucizumab 5g IV." Correction: Idarucizumab (Praxbind) is strictly the reversal agent for Dabigatran (a direct thrombin inhibitor). It is completely ineffective for Factor Xa inhibitors like Apixaban. The correct answer is Andexanet Alfa or 4F-PCC.
• Distractor Trap: "Administer 100 mg of Protamine Sulfate for a patient on an Enoxaparin drip." Correction: The maximum allowable dose of Protamine Sulfate is 50 mg to avoid paradoxical anticoagulation and severe hypotension.
• Buzzword: "Recent knee surgery, now with expanding skin necrosis at the heparin injection site." Suspect Heparin-Induced Thrombocytopenia (HIT).

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Reversal & Resuscitation Phrase: "This patient presents with a clinically significant intracranial hemorrhage while taking a Factor Xa inhibitor, which constitutes a major, life-threatening bleed. I will immediately discontinue the Apixaban. I am ordering Andexanet Alfa using the high-dose protocol based on his last known ingestion time. Simultaneously, I am activating the massive transfusion protocol, establishing two large-bore IVs, securing the airway, and consulting neurosurgery for emergent operative source control."